Morgan Stanley Maintains Overweight on ArcBest, Raises Price Target to $180

Benzinga · 07/06 13:04
Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ:ARCB) with a Overweight and raises the price target from $150 to $180.